Impact of Cognitive Symptoms on Health-Related Quality of Life and Work Productivity in Chinese Patients with Major Depressive Disorder: Results from the PROACT Study

References

• Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547. doi:10.1371/journal.pmed.100154724223526
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang Y, Wang H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211–224. doi:10.1016/S2215-0366(18)30511-X30792114
   PubMed Web of Science ®Google Scholar
• Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2013;381(9882):1987–2015. doi:10.1016/S0140-6736(13)61097-123746901
   PubMed Web of Science ®Google Scholar
• Phillips MR, Zhang J, Shi Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey. Lancet. 2009;373(9680):2041–2053. doi:10.1016/S0140-6736(09)60660-719524780
   PubMed Web of Science ®Google Scholar
• Lao CK, Chan YM, Tong HH, Chan A. Underdiagnosis of depression in an economically deprived population in Macao, China. Asia Pac Psychiatry. 2016;8(1):70–79. doi:10.1111/appy.1220826293902
   PubMed Web of Science ®Google Scholar
• Gupta S, Goren A, Dong P, Liu D. Prevalence, awareness, and burden of major depressive disorder in urban China. Expert Rev Pharmacoecon Outcomes Res. 2016;16(3):393–407. doi:10.1586/14737167.2016.110206226495800
   PubMed Web of Science ®Google Scholar
• IsHak WW, Greenberg JM, Balayan K, et al. Quality of life: the ultimate outcome measure of interventions in major depressive disorder. Harv Rev Psychiatry. 2011;19(5):229–239. doi:10.3109/10673229.2011.61409921916825
   PubMed Web of Science ®Google Scholar
• Woo J-M, Kim W, Hwang T-Y, et al. Impact of depression on work productivity and its improvement after outpatient treatment with antidepressants. Value Health. 2011;14(4):475–482. doi:10.1016/j.jval.2010.11.00621669372
   PubMed Web of Science ®Google Scholar
• Birnbaum HG, Kessler RC, Kelley D, Ben-Hamadi R, Joish VN, Greenberg PE. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance. Depress Anxiety. 2010;27(1):78–89. doi:10.1002/da.2058019569060
   PubMed Web of Science ®Google Scholar
• Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression. JAMA. 2003;289(23):3135–3144. doi:10.1001/jama.289.23.313512813119
   PubMed Web of Science ®Google Scholar
• de Graaf R, Tuithof M, van Dorsselaer S, Ten Have M. Comparing the effects on work performance of mental and physical disorders. Soc Psychiatry Psychiatr Epidemiol. 2012;47(11):1873–1883. doi:10.1007/s00127-012-0496-722434047
   PubMed Web of Science ®Google Scholar
• Allen D, Hines EW, Pazdernik V, Konecny LT, Breitenbach E. Four-year review of presenteeism data among employees of a large United States health care system: a retrospective prevalence study. Hum Resour Health. 2018;16(1):59. doi:10.1186/s12960-018-0321-930413168
   PubMed Web of Science ®Google Scholar
• Ekman M, Granström O, Omérov S, Jacob J, Landén M. The societal cost of depression: evidence from 10,000 Swedish patients in psychiatric care. J Affect Disord. 2013;150(3):790–797. doi:10.1016/j.jad.2013.03.00323611536
   PubMed Web of Science ®Google Scholar
• Evans VC, Iverson GL, Yatham LN, Lam RW. The relationship between neurocognitive and psychosocial functioning in major depressive disorder: a systematic review. J Clin Psychiatry. 2014;75(12):1359–1370. doi:10.4088/JCP.13r0893925551235
   PubMed Web of Science ®Google Scholar
• Lam RW, Kennedy SH, Mclntyre RS, Khullar A. Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment. Can J Psychiatry. 2014;59(12):649–654. doi:10.1177/07067437140590120625702365
   PubMed Web of Science ®Google Scholar
• Knight MJ, Baune BT. Cognitive dysfunction in major depressive disorder. Curr Opin Psychiatry. 2018;31(1):2631. doi:10.1097/YCO.0000000000000378
   Web of Science ®Google Scholar
• McIntyre RS, Cha DS, Soczynska JK, et al. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety. 2013;30(6):515–527. doi:10.1002/da.2206323468126
   PubMed Web of Science ®Google Scholar
• Srisurapanont M, Bautista D, Chen CH, Wang G, Udomratn P, Eurviriyanukul K. Subjective memory and concentration deficits in medication-free, non-elderly Asians with major depressive disorder: prevalence and their correlates. J Affect Disord. 2015;171:105–110. doi:10.1016/j.jad.2014.09.00725303026
   PubMed Web of Science ®Google Scholar
• Clark M, DiBenedetti D, Perez V. Cognitive dysfunction and work productivity in major depressive disorder. Expert Rev Pharmacoecon Outcomes Res. 2016;16(4):455–463. doi:10.1080/14737167.2016.119568827268275
   PubMed Web of Science ®Google Scholar
• Kim JM, Chalem Y, Di Nicola S, Hong JP, Won SH, Milea D. A cross-sectional study of functional disabilities and perceived cognitive dysfunction in patients with major depressive disorder in South Korea: the PERFORM-K study. Psychiatry Res. 2016;239:353–361. doi:10.1016/j.psychres.2016.01.02226908289
   PubMed Web of Science ®Google Scholar
• Manit S, Yee Ming M, Yen Kuang Y, et al. Cognitive dysfunction in Asian patients with depression (CogDAD): a cross-sectional study. Clin Pract Epidemiol Ment Health. 2017;13:185–199. doi:10.2174/174501790171301018529238395
   PubMedGoogle Scholar
• Saragoussi D, Touya M, Haro JM, et al. Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study. Neuropsychiatr Dis Treat. 2017;13:2151–2165. doi:10.2147/NDT.S13634328860772
   PubMed Web of Science ®Google Scholar
• Hammer-Helmich L, Haro JM, Jönsson BT, et al. Functional impairment in patients with major depressive disorder: the 2-year PERFORM study. Neuropsychiatr Dis Treat. 2018;14:239–249. doi:10.2147/NDT.S14609829386897
   PubMed Web of Science ®Google Scholar
• Saragoussi D, Christensen MC, Hammer-Helmich L, Rive B, Touya M, Haro JM. Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study. Neuropsychiatr Dis Treat. 2018;14:1339–1350. doi:10.2147/NDT.S15927629872301
   PubMed Web of Science ®Google Scholar
• Chokka P, Bougie J, Rampakakis E, Proulx J. Assessment in work productivity and the relationship with cognitive symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD). CNS Spectr. 2019;24(3):338–347. doi:10.1017/S109285291800091329792585
   PubMed Web of Science ®Google Scholar
• Chokka P, Bougie J, Proulx J, Holmegaard Tvistholm A, Ettrup A. Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study. CNS Spectr. 2019;24(6):616–627. doi:10.1017/S109285291900078630802419
   PubMed Web of Science ®Google Scholar
• Cambridge OR, Knight MJ, Mills N, Baune BT. The clinical relationship between cognitive impairment and psychosocial functioning in major depressive disorder: a systematic review. Psychiatry Res. 2018;269:157–171. doi:10.1016/j.psychres.2018.08.03330149273
   PubMed Web of Science ®Google Scholar
• Knight MJ, Air T, Baune BT. The role of cognitive impairment in psychosocial functioning in remitted depression. J Affect Disord. 2018;235:129–134. doi:10.1016/j.jad.2018.04.05129655074
   PubMed Web of Science ®Google Scholar
• Wang G, Si T-M, Li L, et al. Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China. Neuropsychiatr Dis Treat. 2019;15:1723–1736. doi:10.2147/NDT.S19550531308667
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62. doi:10.1136/jnnp.23.1.5614399272
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi:10.1046/j.1525-1497.2001.016009606.x11556941
   PubMed Web of Science ®Google Scholar
• Fehnel SE, Forsyth BH, Dibenedetti DB, Danchenko N, François C, Brevig T. Patient-centered assessment of cognitive symptoms of depression. CNS Spectr. 2016;21(1):43–52. doi:10.1017/S109285291300064324067243
   PubMed Web of Science ®Google Scholar
• Shi C, Wang G, Tian F, et al. Reliability and validity of Chinese version of perceived deficits questionnaire for depression in patients with MDD. Psychiatry Res. 2017;252:319–324. doi:10.1016/j.psychres.2017.03.02128314227
   PubMed Web of Science ®Google Scholar
• Lam RW, Lamy FX, Danchenko N, et al. Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder. Neuropsychiatr Dis Treat. 2018;14:2861–2877. doi:10.2147/NDT.S17518830464471
   PubMed Web of Science ®Google Scholar
• Wechsler D. Wechsler Adult Intelligence Scale—Revised. San Antonio, TX, USA: Psychological Corporation; 1981.
   Google Scholar
• Mahableshwarkar AR, Zajecka J, Jacobson W, Chen Y, Keefe RS. A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology. 2015;40(8):2025–2037. doi:10.1038/npp.2015.5225687662
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Harrison J, Loft H, Jacobson W, Olsen CK. The effects of vortioxetine on cognitive function in patients with major depressive disorder: a meta-analysis of three randomized controlled trials. Int J Neuropsychopharmacol. 2016;19(10):pyw055. doi:10.1093/ijnp/pyw05527312740
   PubMed Web of Science ®Google Scholar
• EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208. doi:10.1016/0168-8510(90)90421-910109801
   PubMed Web of Science ®Google Scholar
• Liu GG, Wu H, Li M, Gao C, Luo N. Chinese time trade-off values for EQ-5D health states. Value Health. 2014;17(5):597–604. doi:10.1016/j.jval.2014.05.00725128053
   PubMed Web of Science ®Google Scholar
• Reilly MC, Zbrozek AS, Duke EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–365. doi:10.2165/00019053-199304050-0000610146874
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996;11(Suppl. 3):89–95. doi:10.1097/00004850-199606003-00015
   PubMed Web of Science ®Google Scholar
• Sheehan KH, Sheehan DV. Assessing treatment effects in clinical trials with the Discan metric of the Sheehan Disability Scale. Int Clin Psychopharmacol. 2008;23(2):70–83. doi:10.1097/YIC.0b013e3282f2b4d618301121
   PubMed Web of Science ®Google Scholar
• R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2016 Available from: http://www.R-project.org/. Accessed 218, 2020.
   Google Scholar
• Sumiyoshi T, Watanabe K, Noto S, et al. Relationship of cognitive impairment with depressive symptoms and psychosocial function in patients with major depressive disorder: cross-sectional analysis of baseline data from PERFORM-J. J Affect Disord. 2019;258:172–178. doi:10.1016/j.jad.2019.07.06431426015
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Lophaven S, Olsen CK. A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol. 2014;17(10):1557–1567. doi:10.1017/S146114571400054624787143
   PubMed Web of Science ®Google Scholar
• Zhou T, Guan H, Yao J, Xiong X, Ma A. The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review. Qual Life Res. 2018;27(11):2799–2814. doi:10.1007/s11136-018-1928-y29980994
   PubMed Web of Science ®Google Scholar
• Shi J-F, Huang H-Y, Guo L-W, et al. Quality-of-life and health utility scores for common cancers in China: a multicentre cross-sectional survey. Lancet. 2016;388(Spec. Iss. 1):S29. doi:10.1016/S0140-6736(16)31956-0
   Google Scholar
• Cha DS, Carmona NE, Subramaniapillai M, et al. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): association with psychosocial function in major depressive disorder. J Affect Disord. 2017;222:14–20. doi:10.1016/j.jad.2017.06.03628667888
   PubMed Web of Science ®Google Scholar
• Srisurapanont M, Suttajit S, Eurviriyanukul K, Varnado P. Discrepancy between objective and subjective cognition in adults with major depressive disorder. Sci Rep. 2017;7(1):3901. doi:10.1038/s41598-017-04353-w28634383
   PubMed Web of Science ®Google Scholar
• Fava M, Mahableshwarkar AR, Jacobson W, et al. What is the overlap between subjective and objective cognitive impairments in MDD? Ann Clin Psychiatry. 2018;30(3):176–184.30028891
   PubMed Web of Science ®Google Scholar
• Schwert C, Stohrer M, Aschenbrenner S, Weisbrod M, Schröder A. Biased neurocognitive self-perception in depressive and in healthy persons. J Affect Disord. 2018;232:96–102. doi:10.1016/j.jad.2018.02.03129481997
   PubMed Web of Science ®Google Scholar
• Dehn LB, Beblo T. Are they just exaggerating? Differences between subjective and objective cognitive performance in patients with depression: mounting evidence and open questions. J Affect Disord. 2019;248:198–199. doi:10.1016/j.jad.2018.05.08230777171
   PubMed Web of Science ®Google Scholar
• Evans-Lacko S, Knapp M. Global patterns of workplace productivity for people with depression: absenteeism and presenteeism costs across eight diverse countries. Soc Psychiatry Psychiatr Epidemiol. 2016;51(11):1525–1537. doi:10.1007/s00127-016-1278-427667656
   PubMed Web of Science ®Google Scholar
• Uribe JM, Pinto DM, Vecino-Ortiz AI, Gómez-Restrepo C, Rondón M. Presenteeism, absenteeism, and lost work productivity among depressive patients from five cities of Colombia. Value Health Reg Issues. 2017;14:15–19. doi:10.1016/j.vhri.2017.03.00129254536
   PubMedGoogle Scholar
• Beck A, Crain LA, Solberg LI, et al. The effect of depression treatment on work productivity. Am J Manag Care. 2014;20(8):e294–e301.25295792
   PubMed Web of Science ®Google Scholar
• Lachaine J, Beauchemin C, Bibeau J, et al. Canadian economic impact of improved workplace productivity in patients with major depressive disorder treated with vortioxetine. CNS Spectr. 2019:1–8. doi:10.1017/S1092852919000853.
   Web of Science ®Google Scholar
• Baune BT, Brignone M, Larsen KG. A network meta-analysis comparing effects of various antidepressant classes on the digit symbol substitution test (DSST) as a measure of cognitive dysfunction in patients with major depressive disorder. Int J Neuropsychopharmacol. 2018;21(2):97–107. doi:10.1093/ijnp/pyx07029053849
   PubMed Web of Science ®Google Scholar
• Andresen R, Caputi P, Oades LG. Do clinical outcome measures assess consumer-defined recovery? Psychiatry Res. 2010;177(3):309–317. doi:10.1016/j.psychres.2010.02.01320227768
   PubMed Web of Science ®Google Scholar